Covered recipient · General Payments record
CONRAD H DAUM
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2022
$1,278.28
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $160.73 | 8 |
| Education | $94.49 | 1 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $123.06 | 3 |
| ITI, Inc. | $64.38 | 1 |
| Vanda Pharmaceuticals Inc. | $24.13 | 2 |
| Otsuka America Pharmaceutical, Inc. | $17.61 | 1 |
| Alkermes, Inc. | $13.23 | 1 |
| Lundbeck LLC | $12.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $13.23 | 03/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 925834897 | CMS |
| ITI, Inc. | $64.38 | 04/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945670599 | CMS |
| Lundbeck LLC | $12.81 | 10/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945739967 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.61 | 09/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929277479 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.32 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954505831 | CMS |
| Teva Pharmaceuticals USA, Inc. | $94.49 | 05/19/2022 | Education | Undisputed | 01/23/2026 | 954505973 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.25 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954506093 | CMS |
| Vanda Pharmaceuticals Inc. | $11.85 | 06/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 951960157 | CMS |
| Vanda Pharmaceuticals Inc. | $12.28 | 06/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 951960159 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.